Predictors of noncompliance in males with first-episode schizophrenia, schizophreniform and schizoaffective disorder

European Psychiatry

Volumn 17, Issue 3, 2002, Pages 148-154

  Novak Grubic, Virginija ^a   Tavcar, Rok ^a  

^a UNIVERSITY PSYCHIATRIC HOSPITAL   (Slovenia)

Author keywords

First episode schizophrenia; Noncompliance; Predictors; Relapse

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AKATHISIA; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; RELAPSE; SCHIZOIDISM; SCHIZOPHRENIA; SOCIAL ASPECT;

EID: 0036075821     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(02)00645-4     Document Type: Article

References (34)

1. Which factors modify drug-compliance?
2. Awareness of illness in schizophrenia and schizoaffective and mood disorder
3. Subjective response to antipsychotic drugs: Failure to replicate predictions of outcome
4. A rating scale for drug induced akathisia
5. Clinical symptomatology and drug compliance in schizophrenic patients
6. Determinants of medication compliance in schizophrenia: Empirical and clinical findings
7. Compliance with antipsychotic drug treatment: Influence of side effects
8. One year outcome of schizophrenic patients - The interaction of chronicity and neuroleptic treatment
9. Compliance with neuroleptic medication in outpatients with schizophrenia; realationship to subjective response to neuroleptics; attitudes to medication and insight
10. Age and other factors relevant to the rehospitalization of schizophrenic outpatients
11. Positive and Negative Syndrome Scale (PANSS) for schizophrenia
12. Compliance, quality assurance and standards for relapse prevention in schizophrenia
13. Guidelines for neuroleptic relapse prevention in schizophrenia: Towards a consensus view
14. Insight and adherence to medication in chronic schizophrenics
15. Compliance bei der therapie schizophrener patienten mit neuroleptika - Eine übersicht
16. Outcome in schizophrenia: Beyond symptom reduction
17. The capacity of a measure of disability (the LSP) to predict hospital readmission in those with schizophrenia
18. Medication - Compliance or alliance? A client centred approach to increasing adherence
19. Medication compliance and substance abuse among schizophrenic patients
20. Pharmacotherapy of first-episode schizophrenia
21. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder
22. Demographic factors associated with extreme noncompliance in schizophrenia
23. Effect of patient education on medication compliance
24. Neuroleptic dosing and neuroleptic plasma levels in schizophrenia: Determining the optimal regimen
25. A rating scale for extrapyramidal side effects
26. Memory impairment in schizophrenia: Perspectives from psychopathology and pharmacotherapy
27. Recidivism in Slovenia
28. Dropping out of psychiatric treatment: A prospective study of a first-admission cohort
29. Drug refusal in schizophrenia and the wish to be crazy
30. Cantabria first-episode schizophrenia study: Three-year follow-up
31. Nacela vzdrzevalne nevrolepticne terapije psihoz